MYB117 Antibody

What is MYB117 and what is its function in Arabidopsis?

MYB117, also known as LATERAL ORGAN FUSION1 (LOF1), is an R2R3-MYB transcription factor expressed in organ boundaries in Arabidopsis thaliana. It functions as a negative regulator of flowering time by directly binding to the promoter of FLOWERING LOCUS T (FT) to suppress its expression . MYB117 belongs to the large family of MYB domain proteins, specifically the R2R3-MYB transcription factor subgroup that plays critical roles in plant development, metabolism, and stress responses . Research has demonstrated that MYB117 is involved in boundary specification, meristem initiation and maintenance, and organ patterning . Loss-of-function mutants exhibit early flowering phenotypes under long-day conditions, indicating its important role in controlling the transition to reproductive growth in plants .

How does MYB117 regulate flowering time in Arabidopsis?

MYB117 regulates flowering time by directly binding to the promoter of the FT gene, which serves as a core integrator in flowering regulation networks. Specifically, MYB117 acts as a transcriptional repressor that suppresses FT expression . ChIP-qPCR analysis has demonstrated that MYB117 binds predominantly to the P2 and P3 regions of the FT promoter . In myb117 mutants, FT expression is significantly upregulated, leading to an early flowering phenotype under long-day conditions . The regulatory mechanism appears to be part of a complex flowering control system that integrates various environmental conditions and endogenous factors through the modulation of FT expression . This negative regulation places MYB117 among other transcription factors such as MYB106 and MYB56 that have been shown to control flowering time through direct interaction with the FT promoter .

What methods utilize MYB117 antibody in flowering time research?

MYB117 antibody is primarily used in chromatin immunoprecipitation (ChIP) assays to study the direct binding of MYB117 to target gene promoters. In published research, ChIP-qPCR analysis utilizing MYB117 antibodies with chromatin isolated from wild-type Arabidopsis seedlings has successfully demonstrated direct binding of MYB117 to the FT promoter . The technique involves:

• Crosslinking proteins to DNA in plant tissue

• Fragmenting chromatin

• Immunoprecipitating MYB117-bound DNA fragments using MYB117-specific antibodies

• Analyzing the enriched DNA regions by qPCR

This methodology has revealed that MYB117 preferentially binds to specific regions (particularly P2 and P3) of the FT promoter, providing mechanistic insight into how this transcription factor regulates flowering time . The antibody can also be used in western blot analysis to detect MYB117 protein expression levels in different tissues or under various experimental conditions.

How can researchers validate MYB117 antibody specificity for ChIP experiments?

Validating MYB117 antibody specificity is crucial for accurate ChIP experiments. Researchers should implement a multi-step validation process:

• Antibody validation in wild-type vs. mutant tissues: Compare ChIP signals between wild-type plants and myb117 knockout/knockdown mutants (such as the SALK_025235 and SALK_095232 lines) . The absence or significant reduction of signal in mutant lines confirms antibody specificity.

• Western blot validation: Perform western blots on protein extracts from wild-type and myb117 mutant plants to confirm the antibody recognizes a band of the expected molecular weight only in wild-type samples.

• Negative control regions: Include primers targeting genomic regions not expected to interact with MYB117 in ChIP-qPCR experiments. These should show minimal enrichment compared to positive target regions.

• Positive control targets: Include primers for confirmed binding sites (such as the P2 and P3 regions of the FT promoter) .

• IgG control: Use a non-specific IgG antibody as a negative control for immunoprecipitation to establish background signal levels.

This comprehensive validation approach ensures that ChIP results with MYB117 antibody accurately reflect genuine protein-DNA interactions rather than non-specific binding.

How can transcriptome analysis complement MYB117 antibody-based research?

Transcriptome analysis serves as a powerful complementary approach to antibody-based studies of MYB117 function. RNA sequencing of myb117 mutants has revealed 410 differentially expressed genes compared to wild-type plants, providing a global view of MYB117's regulatory impact . This approach offers several advantages:

• Identification of direct and indirect targets: While ChIP identifies direct binding targets, RNA-seq reveals the broader transcriptional consequences of MYB117 disruption, including both direct targets and downstream effectors.

• Pathway analysis: KEGG pathway analysis of differentially expressed genes in myb117 mutants has identified overrepresented pathways, including protein processing in the endoplasmic reticulum, plant hormone signal transduction, oxidative phosphorylation, and cysteine and methionine metabolism .

• Discovery of novel functions: Transcriptome analysis has suggested MYB117 involvement in multiple biological processes beyond flowering regulation, including genes related to autophagy (ATG8E), stress tolerance (LEA7), trichome development (WRKY44), phosphoinositide signaling (PI4KC3), and meiotic processes (ASY1) .

The integration of ChIP data using MYB117 antibody with transcriptome profiles enables researchers to distinguish between direct binding events and secondary regulatory effects, providing a more comprehensive understanding of MYB117 function in plant development.

What are the challenges in interpreting ChIP-qPCR data with MYB117 antibody?

Interpreting ChIP-qPCR data with MYB117 antibody presents several challenges that researchers should consider:

• Cross-reactivity with related MYB proteins: The R2R3-MYB family in Arabidopsis includes closely related members that share sequence homology. MYB117 belongs to a subgroup that includes other MYB transcription factors involved in flowering regulation, such as MYB106 . Researchers must ensure the antibody specifically recognizes MYB117 without cross-reacting with related proteins.

• Context-dependent binding patterns: MYB117 binding to target promoters may vary depending on developmental stage, tissue type, or environmental conditions. The binding pattern observed in whole seedlings may differ from that in specific tissues where MYB117 is highly expressed, such as flowers .

• Distinguishing functional from non-functional binding: Not all binding events detected by ChIP are functionally relevant. Correlation with expression data from myb117 mutants and dual-luciferase assays is essential to confirm regulatory significance of binding events .

• Quantitative interpretation: ChIP-qPCR results should be carefully normalized and quantitatively assessed. In published studies, MYB117 showed stronger binding to the P2 and P3 regions of the FT promoter compared to other regions, suggesting preferential interaction with specific regulatory elements .

Addressing these challenges requires comprehensive experimental design, including appropriate controls and complementary functional assays.

What mutant lines are available for studying MYB117 function?

Several well-characterized mutant lines are available for studying MYB117 function in Arabidopsis:

These T-DNA insertion lines have been genotyped and confirmed as homozygous knockdown alleles through transcription analysis . Both mutant lines display significantly earlier flowering than wild-type plants, with differences quantified in terms of days to flowering and rosette leaf numbers when the first flower buds emerged . The mutants also exhibit additional developmental phenotypes consistent with MYB117's known roles in lateral organ development and boundary specification .

How can researchers design effective complementation studies for MYB117 mutants?

Designing effective complementation studies for MYB117 mutants requires careful consideration of several factors:

• Construct design: Create an expression construct containing the complete MYB117 coding sequence under the control of either:

  • Native promoter (preferred for physiological relevance)

  • Constitutive promoter (such as CaMV35S) for overexpression studies

• Transformation approach: Transform myb117-1 and myb117-2 mutant plants with the MYB117 expression construct using Agrobacterium-mediated floral dip method .

• Selection and verification:

  • Select transformants on appropriate selective media

  • Confirm transgene integration by PCR

  • Verify MYB117 expression levels by qRT-PCR to ensure restoration of expression comparable to wild-type levels

• Phenotypic analysis:

  • Quantify flowering time parameters (days to flowering, rosette leaf numbers) to determine if wild-type flowering time is restored

  • Examine other developmental phenotypes (lateral organ fusion, embryo development) to assess complete functional complementation

• Molecular verification:

  • Measure FT expression levels by qRT-PCR to confirm restoration of proper FT regulation

  • Perform ChIP-qPCR with MYB117 antibody to verify binding to the FT promoter is restored

This comprehensive approach will provide definitive evidence for MYB117's role in flowering time regulation and other developmental processes.

How does MYB117 expression vary across different tissues in Arabidopsis?

MYB117 shows distinct tissue-specific expression patterns that provide insights into its function:

• High expression in flowers: Tissue-specific qRT-PCR analysis has demonstrated that MYB117 is highly expressed in flower tissues, showing an expression pattern inverse to that of FT . This suggests a specialized role in regulating reproductive development.

• Expression in organ boundaries: As indicated by its alternative name LATERAL ORGAN FUSION1 (LOF1), MYB117 is expressed in organ boundaries where it functions in boundary specification .

• Expression in meristems: MYB117 plays roles in meristem initiation and maintenance, consistent with expression in meristematic regions .

The tissue-specific expression pattern of MYB117 corresponds with its functional roles in both flowering time regulation and developmental patterning. Understanding this expression profile is essential for interpreting antibody-based detection of the protein in different tissue contexts and developmental stages.

What approaches can be used to study tissue-specific functions of MYB117?

Several sophisticated approaches can be employed to study the tissue-specific functions of MYB117:

• Tissue-specific complementation: Transform myb117 mutants with constructs expressing MYB117 under tissue-specific promoters (e.g., floral-specific, meristem-specific, or boundary-specific promoters) to determine in which tissues MYB117 expression is sufficient to rescue different aspects of the mutant phenotype.

• Tissue-specific knockdown/knockout: Use CRISPR-Cas9 with tissue-specific promoters or tissue-specific expression of artificial microRNAs to reduce MYB117 function in specific tissues.

• Immunohistochemistry with MYB117 antibody: Use the MYB117 antibody for in situ protein localization to precisely map protein distribution across tissues and developmental stages.

• Reporter gene fusions: Create MYB117 promoter:GUS or MYB117:GFP fusions to visualize expression patterns and protein localization.

• Cell-type specific transcriptomics: Perform FACS-based isolation of specific cell types followed by RNA-seq to determine cell-type specific impacts of MYB117 disruption.

• Tissue-specific ChIP-seq: Combine tissue-specific nuclei isolation with ChIP-seq using MYB117 antibody to identify tissue-specific binding targets.

These approaches collectively enable dissection of MYB117's diverse functions in different tissues, potentially revealing tissue-specific regulatory mechanisms and target genes.

How does MYB117 interact with other transcription factors in flowering regulation?

MYB117 functions within a complex network of transcription factors that collectively regulate flowering time in Arabidopsis:

• Relationship with other MYB factors: MYB117 belongs to a subgroup of R2R3-MYB transcription factors that includes MYB105 (also known as LATERAL ORGAN FUSION 2), which is involved in lateral organ separation and floral organ development . Phylogenetic analysis places MYB117 in proximity to MYB106 and MYB56, both of which also negatively regulate flowering time through FT .

• Integration with diverse transcription factor families: Multiple transcription factor families regulate FT expression, including:

  • NAC transcription factors

  • WRKY transcription factors

  • PIF4 (a bHLH factor)

  • MYB factors including MYB56, MYB106, and MYB117

• Potential regulatory interactions: Whether these transcription factors influence each other's function or compete for binding sites remains to be fully investigated . Research suggests potential regulatory hierarchies or competitive interactions among these factors.

Understanding these interactions is critical for developing a comprehensive model of flowering time regulation and may inform experimental approaches using MYB117 antibody to detect potential protein-protein interactions.

What methodological approaches can detect interactions between MYB117 and other proteins?

Several methodological approaches utilizing MYB117 antibody can be employed to detect protein-protein interactions:

• Co-immunoprecipitation (Co-IP): Use MYB117 antibody to immunoprecipitate MYB117 from plant extracts, followed by mass spectrometry or western blotting to identify interacting proteins. This approach can reveal stable protein complexes involving MYB117.

• Yeast two-hybrid screening: While not directly using the antibody, this approach can identify potential MYB117 interactors that can then be verified using antibody-based methods.

• Bimolecular Fluorescence Complementation (BiFC): Combine with MYB117 antibody immunolocalization to confirm the cellular contexts of interactions.

• Chromatin Immunoprecipitation followed by Mass Spectrometry (ChIP-MS): Use MYB117 antibody to pull down chromatin-associated complexes, then identify co-binding proteins by mass spectrometry.

• Sequential ChIP (Re-ChIP): Perform ChIP with MYB117 antibody followed by a second immunoprecipitation with antibodies against suspected interacting transcription factors to identify co-occupied genomic regions.

• Proximity-dependent biotin identification (BioID): Use a MYB117-BioID fusion protein to biotinylate proximal proteins, then verify interactions using MYB117 antibody in parallel analyses.

These approaches can reveal if MYB117 physically interacts with other flowering regulators like MYB106, MYB56, or components of the proteasomal degradation machinery that may regulate MYB117 stability .

How might protein degradation pathways regulate MYB117 activity?

Evidence suggests that protein degradation pathways may play an important role in regulating MYB117 activity:

• Potential role of CRL3 BPM complex: Related MYB transcription factors, including MYB106 and MYB56, have been identified as substrates of the CRL3 BPM E3 ligase complex, leading to their proteasomal degradation . Given the functional similarities between these proteins and MYB117, researchers have hypothesized that MYB117 protein stability may similarly be regulated by E3 ligases and subsequent proteasomal degradation .

• Protein stability regulation impacts FT expression: The regulation of MYB117 protein turnover would directly influence its ability to bind to the FT promoter and repress FT expression, thereby affecting flowering time .

• Experimental approaches: Researchers can use MYB117 antibody in several approaches to investigate this regulatory mechanism:

  • Western blot analysis to monitor MYB117 protein levels under various conditions

  • Co-immunoprecipitation to detect associations with components of the proteasome pathway

  • In vitro ubiquitination assays with recombinant MYB117 and E3 ligase components

  • Treatment with proteasome inhibitors to assess changes in MYB117 protein levels

This potential layer of post-translational regulation adds complexity to MYB117 function and may explain how environmental or developmental signals modulate its activity.

What experimental designs can assess post-translational modifications of MYB117?

Researchers can employ several experimental approaches to investigate post-translational modifications (PTMs) of MYB117:

• Mass spectrometry analysis:

  • Immunoprecipitate MYB117 using specific antibodies from plant tissues

  • Perform LC-MS/MS analysis to identify phosphorylation, acetylation, SUMOylation, or other PTMs

  • Compare modification patterns under different conditions (e.g., different photoperiods, developmental stages)

• Phospho-specific antibody development:

  • Generate antibodies that specifically recognize phosphorylated forms of MYB117

  • Use these alongside general MYB117 antibodies to determine phosphorylation status under various conditions

• In vitro modification assays:

  • Express recombinant MYB117 protein

  • Incubate with plant extracts containing active kinases, acetyltransferases, or other modifying enzymes

  • Detect modifications using MYB117 antibody in western blots, looking for mobility shifts

• Mutational analysis:

  • Create site-directed mutants of predicted modification sites

  • Express in myb117 mutants

  • Assess protein function, stability, and localization using MYB117 antibody

  • Determine flowering time phenotypes

• Inhibitor studies:

  • Treat plants with inhibitors of specific PTM pathways

  • Monitor changes in MYB117 protein levels, localization, or function using MYB117 antibody

These approaches can reveal how PTMs regulate MYB117 activity and provide insights into the signaling pathways that modulate flowering time through this transcription factor.

What genome-wide approaches can expand our understanding of MYB117 function?

Several genome-wide approaches can significantly advance our understanding of MYB117 function:

• ChIP-sequencing (ChIP-seq):

  • Perform ChIP with MYB117 antibody followed by next-generation sequencing

  • Identify all genomic binding sites of MYB117 beyond the currently known FT promoter

  • Analyze binding motifs to determine sequence preferences

  • Compare binding patterns across different developmental stages or environmental conditions

• Cut&Run or CUT&Tag:

  • These newer techniques offer higher resolution and lower background than traditional ChIP

  • Can be performed with fewer cells, enabling tissue-specific analysis of MYB117 binding

• DAP-seq (DNA affinity purification sequencing):

  • Use purified MYB117 protein to identify potential binding sites in vitro

  • Compare with in vivo ChIP-seq data to distinguish between direct binding capacity and context-dependent binding

• Assay for Transposase-Accessible Chromatin with sequencing (ATAC-seq):

  • Compare chromatin accessibility in wild-type and myb117 mutant plants

  • Identify regions where MYB117 may influence chromatin structure

• HiChIP or ChIA-PET:

  • Combine chromosome conformation capture with MYB117 ChIP

  • Identify long-range chromatin interactions mediated by MYB117

These approaches would expand our understanding beyond the 410 differentially expressed genes already identified in myb117 mutants and provide mechanistic insights into the broader regulatory functions of this transcription factor.

How can researchers integrate MYB117 function into comprehensive flowering regulatory networks?

Integrating MYB117 function into comprehensive flowering regulatory networks requires multifaceted approaches:

• Network modeling:

  • Combine ChIP-seq data of MYB117 with existing datasets for other flowering regulators

  • Construct mathematical models of gene regulatory networks

  • Simulate network responses to environmental changes and genetic perturbations

  • Validate model predictions with experimental data

• Multi-omics integration:

  • Correlate MYB117 binding data (ChIP-seq) with:

    • Transcriptome data (RNA-seq)

    • Epigenomic data (DNA methylation, histone modifications)

    • Chromatin accessibility data (ATAC-seq)

  • Identify coordinately regulated genes and pathways

• Genetic interaction studies:

  • Create double mutants between myb117 and other flowering regulators

  • Analyze epistatic relationships to position MYB117 within hierarchical pathways

  • Use MYB117 antibody to assess protein levels and binding in various genetic backgrounds

• Environmental response profiling:

  • Analyze MYB117 binding and activity across different environmental conditions

  • Determine how MYB117 function integrates environmental signals into flowering decisions

• Comparative studies across species:

  • Investigate orthologs of MYB117 in other plant species

  • Develop species-specific antibodies for comparative ChIP studies

  • Determine conservation and divergence of MYB117 function in flowering regulation

These integrated approaches would place MYB117 within the broader context of flowering regulation, connecting it to other key regulators and pathways involved in this complex developmental transition.